Psoriasis Pathways & Immune Regulation

Psoriatic lesions develop when T-cell responses spiral into chronic overactivation. Some patients show elevated IL-23 activity long before visible symptoms appear. Thick plaques often arise from uncontrolled keratinocyte hyperproliferation. External weather changes influence flare timing significantly. Biologic therapies now block inflammation with greater precision.

Immune-Care Elements:

  • Trigger Avoidance Strategies
  • Immune Cycle Assessments
  • Long-Term Symptom Control

    Related Conference of Psoriasis Pathways & Immune Regulation

    February 05-06, 2026

    9th Annual Conference on Skin Cancer and Dermatology

    Paris, France
    April 16-17, 2026

    9th World Cosmetic and Dermatology Congress

    Paris, France
    June 15-16, 2026

    COSMETIC DERMATOLOGY 2026

    Paris, France
    June 22-23, 2026

    28th World Dermatology and Aesthetic Congress

    London, UK
    June 25-26, 2026

    27th World Dermatology Congress

    Paris, France
    July 20-21, 2026

    20th International Conference on Alzheimers Disease & Dementia

    Amsterdam, Netherlands
    August 25-26, 2026

    26th European Dermatology Congress

    Paris, France
    September 23-24, 2026

    9th International Dermatology Conference: Skin and Body

    Barcelona, Spain

    Psoriasis Pathways & Immune Regulation Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in